While several strategies to deprive cancer cells of nutrients have been contemplated (Pathria and Ronai, 2021), our results suggest that inhibition of GCN2 represents a unique treatment paradigm to starve prostate tumors of EAAs. The gene discussed is EIF2AK4; the disease is cancer.